期刊文献+

双相障碍患者与正常人血浆孤啡肽水平的对照研究 被引量:1

Plasma levels of nociceptin/orphanin FQ in patients with bipolar disorders and health adults
原文传递
导出
摘要 目的探讨血浆孤啡肽(OFQ)水平与双相障碍的关系,为双相障碍的发病机制、诊断等寻找新的生物学指标。方法筛选47例双相障碍患者(抑郁组21例、躁狂组26例)和31名正常人,应用放射免疫(RIA)法分别测定其血浆OFQ浓度,比较病例组与对照组血浆OFQ水平,病例组OFQ含量与各量表总分的相关性。结果(1)抑郁组OFQ水平高于对照组(t=5.28,P〈0.01);躁狂组OFQ水平低于对照组(t=-2.47,P〈0.05)。差异均具有统计学意义。(2)抑郁组OFQ含量与HAMD、MADRS总分呈显著正相关(r=0.607,P〈0.01;r=0.541,P〈0.05);躁狂组OFQ含量与BRMS总分呈显著负相关(r=-0.750,P〈0.01)。结论血浆OFQ水平的变化可能参与了双相障碍的发生机制并可能反映病情的严重程度,为临床上寻找双相障碍的客观诊断依据及其判断疾病严重程度提供了可能的新的生物学指标。 Objective To investigate the plasma levels of nociceptin/orphanin FQ (OGQ) in patients with bipolar depression and bipolar mania and to analyze the relationship of plasma OFQ to bipolar disorders. Methods Peripheral blood samples were collected from 21 patients with bipolar Ⅱ depression (BD group), 26 patients with bipolar Ⅰ mania (BM group), and 31 health adults (control group). The concentrations of plasma OFQ were measured by radioimmunoassay ( RIA ). The psychological status was examined by Hamilton Depression Scale (HAMD), Bech-Rafaelsen Mania Rating Scale (BRMS), and Montgomery and Asberg Depression Rating Scale (MADRS). Results The plasma OFQ level of the BD group was (20±4 ) rig/L, signifgcantly higher than that of the control group [ ( 14 ± 5 ) ng/L, t = 5.28 ,P 〈 0.01 ], and the OFQ level of the BM group was ( 11 ± 3 ) ng/L, significantly lower than that of the control group (t = -2.47 ,P 〈0.05 ). There were not significant differences in the plasma OFQ between the males and females in all groups ( all P 〉 0.05 ). In the BD group the plasma OFQ level was significantly positively correlated with HAMD and MADRS scoreds ( r = 0. 607, P 〈 0.01 ; r = 0. 541, P 〈 0.05 ). In the BM group the plasma OFQ level was significantly negatively correlated with the BRM score (r = -0.750,P 〈 0.01 ). Conclusion The changes of plasma OFQ level may play a role in the pathogenesis of bipolar disorder and indicate the severity of disease. Plasma OFQ may be a new biological parameter of bipolar disorder.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第13期916-918,共3页 National Medical Journal of China
基金 山东省卫生厅科研基金资助项目(2005HW115)
关键词 双相障碍 孤啡肽 患者 临床研究 Bipolar Disorder Nociceptin
  • 相关文献

参考文献13

  • 1Reinscheid RK, Nothacker HP, Bourson A, et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 1995, 270:792-794.
  • 2Witta J, Palkovits M, Rosenberger J, et al. Distribution of nociceptin/orphanin FQ in adult human brain. Brain Res, 2004, 997 : 24 -29.
  • 3Berger B, Rothmaier AK, Franziska W, et al. Prosynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br J Pharmacol, 2006, 148: 795~06.
  • 4Gyenge M, Hantos M, Laufer R, et al. Effect of nociceptin on histamine and serotonin release in the central nervous system. Acta Pharm Hung, 2006, 76 : 127-132.
  • 5Tao R, Ma Z, Thakkar MM, et al. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu- opioid-induced increases in serotonin efflux. Neuroscience, 2007,147 : 106-116.
  • 6Marti M, Stocchi S, Paganini F, et al. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5- hydroxytryptamine and noradrenaline release in the rat neocortex. Br J Phamracol, 2003, 138:91-98.
  • 7Liu Z, Wang Y, Zhang J, et al. Orphanin FQ: an endogenous antagonist of rat brain dopamine transporter. Neuroreport, 2001, 12:699 -702.
  • 8Kotlinska J, Rafalski P, Biala G, et al. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur J Pharmacol, 2003,474 ( 2- 3) :233-239.
  • 9Zaveri N. Peptide and nonpeptide ligands for the nociceptin/ orphanin FQ receptor ORL1 : research tools and potential therapeutic agents. Life Sci, 2003, 73:663-678.
  • 10Gavioli EC, Marzola G, Guerrini R, et al. Blockade of nociceptin/orphanin FQ-NOP receptor signaling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci, 2003, 17 : 1987-1990.

二级参考文献13

  • 1Judd AK, Kaushanskaya A, Tuttle DJ, et al. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists. J Pept Res, 2003, 62(5):191-8
  • 2Kotlinska J, Rafalski P, Biala G,et al. Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats.Eur J Pharmacol,2003,474(2-3):233-9
  • 3Zaveri N. Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci, 2003,73(6):663-78
  • 4Fernandez F, Misilmeri MA, Felger JC, et al. Nociceptin/ orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology, 2004, 29(1):59-71
  • 5Mamiya T, Yamada K, Miyamoto Y, et al. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-D-aspartate receptors.Mol Psychiatry, 2003, 8(8):752-65
  • 6Takita K, Morimoto Y, Kemmotsu O. Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptordulla in respiratory rhythm generation in the medulla oblongata: an in vitro study. Neurosci Lett, 2003,348 (3): 167-70
  • 7Ouagazzal AM, Moreau JL, Pauly-Evers M, et al. Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/ orphanin FQ peptide precursor gene. Behav Brain Res, 2003, 144(1-2):111-7
  • 8Smith PA, Moran TD. The nociceptin receptor as a potential target in drug design. Drug News Perspect,. 2001, 14(6):335-45
  • 9Marti M, Stocchi S, Paganini F, et al. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. Br J Pharmacol, 2003, 138(1):91-8
  • 10Mela F, Marti M, Ulazzi L, et al. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci, 2004, 19(5):1317-24

共引文献9

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部